EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Polygenic Risk Score Implementation into Clinical Practice for Primary Prevention of Cardiometabolic Disease

Julia Hughes iD, Mikayla Shymka iD, Trevor Ng, Jobanjit S Phulka iD, Sina Safabakhsh iD, Zachary Laksman

Genes · 09.12.2024 · 15 (12) · 1581

DOI: 10.3390/genes15121581 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 09.12.2024. Verfasst von Julia Hughes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, BC V5M 1M9, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Multifactorial Inheritance, Primary Prevention. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease is a leading cause of mortality globally and a major contributor to disability. Traditional risk factors, as initially established in the FRAMINGHAM study, have helped to stratify populations and identify patients for early intervention. Incorporating genetic factors enhances risk stratification tools, enabling the earlier identification of individuals at increased risk and facilitating more targeted and effective risk factor modifications. While monogenic risk variants are present in a minority of the population, polygenic risk scores (PRS) are collections of multiple single-nucleotide variants that collectively provide summative risk and capture a more accurate risk score for a greater number of people. PRS have demonstrated clear utility in cardiometabolic diseases by predicting onset, progression, and therapeutic response.

Methods

A structured and exploratory hybrid search strategy was employed, combining keyword-based database searches and supplementary techniques to comprehensively synthesize the literature on PRS implementation in clinical practice.

Discussion

A comprehensive overview of PRS in cardiometabolic diseases and their potential avenues for integration into primary care is discussed. First, we examine the implementation of genetic screening, risk communication, and intervention strategies through the lens of the American Heart Association’s implementation criteria, focusing on their efficacy, minimization of harm, and logistical considerations. Then, we explores how the varied perceptions of patients and practitioners towards PRS can influence both adoption and utilization. Lastly, we addresses the need for the development of clear guidelines and regulations to support this process, ensuring PRS integration is both scientifically sound and ethically responsible. Future directions: Initiatives aimed at advancing personalized approaches to disease prevention will enhance health outcomes. Developing guidelines for the responsible use of PRS by establishing benefits, while mitigating risk, will a key factor in implementation for clinical utility.

Conclusions

For integration into clinical practice, we must address both patient and provider concerns and experience. Standardized guidelines and training will help to effectively implement PRS into clinical practice. Developing these resources will be essential for PRS to fulfill its potential in personalized, patient-centered care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMultifactorial InheritancePrimary PreventionHumansGenetic Predisposition to DiseaseGenetic TestingRisk AssessmentPolymorphism, Single NucleotideRisk FactorsCardiometabolic Risk FactorsMetabolic DiseasesGenetic Risk Score

Stichwörter der Autor:innen

cardiometabolicpolygenic risk scoresprimary prevention

Autor:innen und Institutionen

  • Department of Medicine, University of British Columbia, Vancouver, BC V5M 1M9, Canada.
  • Centre for Heart Lung Innovation (HLI), Vancouver, BC V6Z 1Y6, Canada.
  • School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 2B9, Canada.

ORCID-Profile: Julia Hughes, Mikayla Shymka, Jobanjit S Phulka, Sina Safabakhsh

Zitieren

APA

Hughes, J., Shymka, M., Ng, T., Phulka, J. S., Safabakhsh, S., & Laksman, Z. (2024). Polygenic Risk Score Implementation into Clinical Practice for Primary Prevention of Cardiometabolic Disease. Genes, 15(12), 1581. https://doi.org/10.3390/genes15121581

Vancouver

Hughes J, Shymka M, Ng T, Phulka JS, Safabakhsh S, Laksman Z. Polygenic Risk Score Implementation into Clinical Practice for Primary Prevention of Cardiometabolic Disease. Genes. 2024;15(12):1581. doi:10.3390/genes15121581

BibTeX
@article{Hughes2024,
  author = {Hughes, Julia and Shymka, Mikayla and Ng, Trevor and Phulka, Jobanjit S and Safabakhsh, Sina and Laksman, Zachary},
  title = {Polygenic Risk Score Implementation into Clinical Practice for Primary Prevention of Cardiometabolic Disease},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {12},
  pages = {1581},
  doi = {10.3390/genes15121581}
}
Kostenlos starten →